Obalon Therapeutics, Inc.
OBLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,042 | -$2,630 | $1,474 | -$1,634 |
| Dep. & Amort. | $1 | $4 | $4 | -$223 |
| Deferred Tax | $6 | -$2 | -$4 | $6 |
| Stock-Based Comp. | $547 | $12 | $15 | $379 |
| Change in WC | $156 | -$156 | $0 | -$1,128 |
| Other Non-Cash | $11,674 | -$1,722 | -$3,608 | $3,877 |
| Operating Cash Flow | $4,342 | -$4,494 | -$2,119 | $1,277 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $250 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | -$15,617 | $10,859 | $4,758 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$5,207 |
| Investing Cash Flow | -$15,617 | $10,859 | $4,758 | -$4,957 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $680 | $0 | $0 | $45 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,157 | $6,101 | $3,947 | -$35,610 |
| Financing Cash Flow | -$2,157 | $6,101 | $3,947 | -$35,610 |
| Forex Effect | -$10 | $1 | -$6 | -$73 |
| Net Chg. in Cash | $1,484 | $1,608 | $1,822 | -$39,420 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,223 | $2,615 | $793 | $40,213 |
| End Cash | $5,707 | $4,223 | $2,615 | $793 |
| Free Cash Flow | $4,342 | -$4,494 | -$2,119 | $1,527 |